Sport Investors League
  • Politics
  • Stocks
  • Investing
  • Business

Sport Investors League

  • Politics
  • Stocks
  • Investing
  • Business
Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Related Posts

Heritage Intersects ~46 Metre Quartz-Sulfide Vein in second...

May 16, 2025

Drilling Planned for Resource Expansion at Whundo Copper...

December 5, 2024

Strategic Investment from Sichuan Hebang Biotechnology

August 3, 2024

Horn Island Mining Lease Application Registered

August 15, 2025

Sona Nanotech to Showcase Its THT Cancer Therapy...

November 8, 2024

Noble and Canada Nickel Announce Signing of Definitive...

January 8, 2025

Top 5 Canadian Mining Stocks This Week: American...

October 12, 2024

AERO ENERGY AND FORTUNE BAY ANNOUNCE COMMENCEMENT OF...

September 27, 2025

WPIC: Platinum to Hit Third Annual Deficit as...

September 12, 2025

Top 10 Silver-producing Countries

August 20, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • Hegseth erupts over WaPo ‘fake stories,’ vows to stop ‘poisoning of the American people’

      December 4, 2025
    • Pentagon probe into secret Signal chats on Houthi strikes set to drop Thursday as Hegseth faces scrutiny

      December 4, 2025
    • Trump admin targets anti-Christian violence with new visa crackdown policy following Nigeria attacks

      December 4, 2025
    • Jack Smith subpoenaed for deposition with House Judiciary Committee

      December 4, 2025
    • IG finds Hegseth’s use of Signal for Houthi strike planning risked harm to US mission and pilots, sources say

      December 4, 2025

    Categories

    • Business (1,143)
    • Investing (3,630)
    • Politics (4,396)
    • Stocks (1,155)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sportinvestorsleague.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 sportinvestorsleague.com | All Rights Reserved